Terms: = Ovarian cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Clinical Outcome
10 results:
1. A bioinformatics analysis: ZFHX4 is associated with metastasis and poor survival in ovarian cancer.
Zong S; Xu PP; Xu YH; Guo Y
J Ovarian Res; 2022 Aug; 15(1):90. PubMed ID: 35915456
[TBL] [Abstract] [Full Text] [Related]
2. Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma.
Zhou H; Liu Q; Shi X; Liu Y; Cao D; Yang J
J Ovarian Res; 2020 Apr; 13(1):38. PubMed ID: 32295618
[TBL] [Abstract] [Full Text] [Related]
3. Using evidence to direct quality improvement efforts: Defining the highest impact complications after complex cytoreductive surgery for ovarian cancer.
Narasimhulu DM; Bews KA; Hanson KT; Chang YH; Dowdy SC; Cliby WA
Gynecol Oncol; 2020 Feb; 156(2):278-283. PubMed ID: 31785863
[TBL] [Abstract] [Full Text] [Related]
4. MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.
Tung CH; Kuo LW; Huang MF; Wu YY; Tsai YT; Wu JE; Hsu KF; Chen YL; Hong TM
Oncogene; 2020 Jan; 39(4):862-876. PubMed ID: 31570789
[TBL] [Abstract] [Full Text] [Related]
5. Circulating and disseminated tumor cells in ovarian cancer: a systematic review.
Romero-Laorden N; Olmos D; Fehm T; Garcia-Donas J; Diaz-Padilla I
Gynecol Oncol; 2014 Jun; 133(3):632-9. PubMed ID: 24657303
[TBL] [Abstract] [Full Text] [Related]
6. Architectural versus nuclear atypia-defined FIGO grade 2 endometrial endometrioid adenocarcinoma (EEC): a clinicopathologic comparison of 154 cases with clinical follow-up.
Winham WM; Lin D; Stone PJ; Nucci MR; Quick CM
Int J Gynecol Pathol; 2014 Mar; 33(2):120-6. PubMed ID: 24487465
[TBL] [Abstract] [Full Text] [Related]
7. ovarian cancer patients with localized relapse: clinical outcome and prognostic factors.
Petrillo M; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Vizzielli G; Pedone Anchora L; Nero C; Margariti PA; Scambia G
Gynecol Oncol; 2013 Oct; 131(1):36-41. PubMed ID: 23791829
[TBL] [Abstract] [Full Text] [Related]
8. Obesity-associated adipokines correlate with survival in epithelial ovarian cancer.
Diaz ES; Karlan BY; Li AJ
Gynecol Oncol; 2013 May; 129(2):353-7. PubMed ID: 23402904
[TBL] [Abstract] [Full Text] [Related]
9. Genetic polymorphisms as predictive and prognostic biomarkers in gynecological cancers: a systematic review.
Diaz-Padilla I; Amir E; Marsh S; Liu G; Mackay H
Gynecol Oncol; 2012 Feb; 124(2):354-65. PubMed ID: 22063461
[TBL] [Abstract] [Full Text] [Related]
10. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS
Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712
[TBL] [Abstract] [Full Text] [Related]
